The National Institute of Allergy and Infectious Diseases (NIAID), the National
Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the
National Heart, Lung and Blood Institute (NHLBI), the National Institute of
Neurological Disorders and Stroke (NINDS), and the Office of Research on Women"s
Health (ORWH) invite investigator-initiated research applications for mechanistic
studies in clinical trials of immunomodulatory interventions for immune system
mediated diseases, including asthma and allergy, graft failure in solid organ and
stem cell transplantation, and autoimmune diseases. Specifically, this Request
for Applications (RFA) focuses on the utilization of patients and patient
materials from such trials for the evaluation of immunologic and other relevant
parameters in order to study the mechanisms underlying the intervention, the
mechanisms of disease pathogenesis, surrogate markers of disease activity and
therapeutic effect, and mechanisms of human immunologic function. The parent or
core clinical trial must have independent financial support and will NOT receive
support under this RFA. Mechanistic studies in clinical trials supported by
industry are particularly encouraged but clinical trials supported by any source,
public or private, are eligible.
Find Funding Opportunities
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Expiration Date: Saturday, October 10, 1998 NOFO Number: RFA-AI-98-006 Release Date: Monday, May 11, 1998 Notice Type: RFA
Expiration Date: Friday, April 6, 2001 NOFO Number: PA-98-053 Release Date: Monday, April 6, 1998 Notice Type: PA
The purpose of the Midcareer Investigator Award in Patient-Oriented Research
(K24) is to provide support for clinicians to allow them protected time to devote
to patient-oriented research and to act as mentors for beginning clinical
investigators. The target candidates are outstanding clinical scientists engaged
in patient-oriented research who are within 15 years of their specialty training,
who can demonstrate the need for a period of intensive research focus as a means
of enhancing their clinical research careers, and who are committed to mentoring
the next generation of clinical investigators focussing on patient-oriented
research. The award is intended to further the research and mentoring endeavors
of outstanding patient-oriented investigators, enable them to expand their
potential to make significant contributions to their field of patient-oriented
research, and to act as mentors for beginning clinicians.
Expiration Date: Friday, April 6, 2001 NOFO Number: PA-98-052 Release Date: Monday, April 6, 1998 Notice Type: PA
The purpose of the Mentored Patient-oriented Research Career Development Award
(K23) is to support the career development of investigators who have made a
commitment to focus their research endeavors on patient-oriented research. This
mechanism provides support for a period of supervised study and research for
clinically trained professionals who have the potential to develop into
productive, clinical investigators focussing on patient-oriented research.
Expiration Date: Tuesday, March 27, 2001 NOFO Number: PA-98-050 Release Date: Friday, March 27, 1998 Notice Type: PA
The purpose of this Program Announcement (PA) is to encourage submission of new
research project grant (R01) and exploratory/developmental research grant (R21)
applications to develop innovative technologies, methodologies, or
instrumentation for the study of the biology of the brain. Research is solicited
that will explore new approaches, test imaginative new ideas, and challenge
existing paradigms in technologies to study the development, structure, function,
and aging of the brain in both human and animal models. Also solicited is
research that will develop significant enhancements to existing technologies
important to neuroscience, and research that will translate a scientific concept
into the basis for a future technology that may advance understanding of
important neuroscience research problems. It is emphasized that the research
solicited can include tools and approaches that relate to any and all aspects of
neuroscience.
Expiration Date: Friday, June 12, 1998 NOFO Number: RFA-HD-98-007 Release Date: Friday, March 27, 1998 Notice Type: RFA
The Mental Retardation and Developmental Disabilities Branch (MRDD), Center for
Research for Mothers and Children (CRMC), of the National Institute of Child
Health and Human Development (NICHD), and the Division of Fundamental
Neuroscience and Developmental Disorders (DFNDD) of the National Institute of
Neurological Disorders and Stroke (NINDS), in collaboration with the National
Down Syndrome Society (NDSS), invite research grant applications that address
various aspects of cognition and behavior in individuals with Down Syndrome (DS).
Areas of interest include the developmental and neurological mechanisms
underlying characteristic loss of function, approaches toward preserving or
improving level of function, and methods to assess effects of interventions. Six
to seven awards may be funded under this grant solicitation subject to the
availability of funds.
Expiration Date: Thursday, July 16, 1998 NOFO Number: RFA-AR-98-006 Release Date: Thursday, March 26, 1998 Notice Type: RFA
The Rheumatic Diseases Program of the National Institute of Arthritis and
Musculoskeletal and Skin Diseases (NIAMS), Chronic Disabling Diseases Program,
National Institute of Dental Research (NIDR), Division of Convulsive, Infectious
and Immune Disorders, National Institute of Neurological Disorders and Stroke
(NINDS), Office of Alternative Medicine (OAM), Office of Behavioral and Social
Sciences Research (OBSSR), and the Office of Research on Women"s Health (ORWH)
invite research grant applications (R01) and exploratory/developmental grants
(R21) from interested investigators for tightly focused innovative research
studies related to all aspects of pathogenesis and clinical manifestations of
fibromyalgia syndrome (FMS) and to relationships between FMS and
temporomandibular disorders (TMDs). Improved understanding of the origins and
the biological, neurological and psychosocial mechanisms underlying the clinical
manifestations of fibromyalgia syndrome will have an impact on the development
of more effective diagnostic tests and new therapies for both FMS and related
disorders.
Expiration Date: Tuesday, March 20, 2001 NOFO Number: PA-98-044 Release Date: Friday, March 20, 1998 Notice Type: PA
The National Institute of Neurological Disorders and Stroke (NINDS) and the
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
encourage investigator-initiated research grant applications to study the
pathogenesis and therapy of the various forms of muscular dystrophy in children
and adults. Responses to this program announcement may include studies in
appropriate animal models or preclinical or clinical studies in patients with
facioscapulohumeral dystrophy (FSH), limb-girdle muscular dystrophy (LGMD),
myotonic dystrophy, congenital muscular dystrophy (CMD), Emery-Dreifuss muscular
dystrophy (EMD), Duchenne muscular dystrophy (DMD), Becker muscular dystrophy
(BMD), or other forms of muscular dystrophy.
Expiration Date: Saturday, June 6, 1998 NOFO Number: RFA-MH-98-009 Release Date: Thursday, March 12, 1998 Notice Type: RFA
This Request for Applications (RFA) solicits grant applications to develop and
implement a procedure for collection of Central Nervous System (CNS) tissues from
HIV infected patients through a standardized autopsy protocol. Applications
responding to this RFA must describe a process for recruitment and selection of
HIV-infected individuals into a protocol that will include regular assessments
of neurological status, assessment of drug use history with verification by
objective measures when possible, regular blood and CSF collection for
virological and serological studies, and implementation of the necessary events
culminating in the collection of CNS tissue at autopsy. Of particular interest
to NIDA is documentation of drug use history and verification by objective
measures when possible. A standardized autopsy protocol, developed during
several workgroups with participation of contributing Institute Program staff and
extramural researchers, has been recommended, and applicants should use this
protocol in their research design.
Expiration Date: Sunday, February 25, 2001 NOFO Number: PAS-98-033 Release Date: Wednesday, February 25, 1998 Notice Type: PAS
The National Institutes of Health (NIH) is committed to investigating the
efficacy of acupuncture for treating or preventing disease and accompanying
symptoms by supporting well-designed, well-executed, randomized clinical trials
(RCT). Before proceeding to a full-scale RCT, pilot clinical studies are often
required. In the present program announcement (PA), the NIH announces its
interest in supporting pilot studies to establish the methodological feasibility
and strengthen the scientific rationale for proceeding to full-scale RCTs on the
use of acupuncture to prevent, manage, or treat various symptoms/disorders. The
emphasis of these pilot trials should be placed on the development of appropriate
study design rather than on attempts to complete an insufficiently powered RCT.
For the purposes of this PA, trials of acupuncture incorporating moxibustion or
herbal medicine will not be considered. Under this PA, applications will be
accepted on a single application receipt date and reviewed by a Special Emphasis
Panel (SEP) administered through the Center for Scientific Review (CSR).
Expiration Date: Friday, February 23, 2001 NOFO Number: PA-98-030 Release Date: Monday, February 23, 1998 Notice Type: PA
The National Institute of Nursing Research (NINR), National Institute on Aging
(NIA), National Institute of Child Health and Human Development (NICHD), National
Institute on Deafness and Other Communication Disorders (NIDCD), and National
Institute of Neurological Disorders and Stroke (NINDS) are interested in
facilitating investigator-initiated research designed to deal with symptoms
associated with chronic neurological conditions including stroke, epilepsy, brain
and spinal cord injury, multiple sclerosis, and Parkinson"s disease. The overall
goals are to manage symptoms effectively, to prevent secondary effects of the
condition when possible, to maximize the health potential, and to improve the
health-related quality of life for patients, caregivers, and families.